[
  {
    "ts": null,
    "headline": "GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications",
    "summary": "GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.",
    "url": "https://finnhub.io/api/news?id=ede31a9c246da17fa32de62796ea2c70a5c5b41f4615f4a26505ae3fdf6f6b8b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750860180,
      "headline": "GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications",
      "id": 135526675,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.",
      "url": "https://finnhub.io/api/news?id=ede31a9c246da17fa32de62796ea2c70a5c5b41f4615f4a26505ae3fdf6f6b8b"
    }
  }
]